Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1M Buy
495,300
+254,300
+106% +$9.14M ﹤0.01% 2510
2026
Q1
$7.74M Buy
241,000
+65,900
+38% +$2.42M ﹤0.01% 3631
2025
Q4
$6.72M Buy
175,100
+98,200
+128% +$2.15M ﹤0.01% 3837
2025
Q3
$1.06M Buy
76,900
+30,000
+64% +$352K ﹤0.01% 7424
2025
Q2
$606K Sell
46,900
-54,100
-54% -$562K ﹤0.01% 8176
2025
Q1
$1.14M Buy
101,000
+26,600
+36% +$349K ﹤0.01% 6689
2024
Q4
$975K Buy
74,400
+69,200
+1,331% +$1.78M ﹤0.01% 7079
2024
Q3
$208K Buy
5,200
+2,200
+73% +$80K ﹤0.01% 10065
2024
Q2
$88.5K Buy
+3,000
New +$81.7K ﹤0.01% 11087

Other funds holding PACS

Citadel Advisors's PACS Position: Q2 2026 in Review

Citadel Advisors reduced its PACS Group (PACS) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 144,242 shares worth $6.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4371.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. The position peaked at $25.2M in Q2 2024. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Citadel Advisors held 144,242 shares of PACS Group worth $6.15M as of Q2 2026.
  • Citadel Advisors sold 470,572 PACS Group shares in Q2 2026, an estimated $16.9M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4371 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.